BioIntellisense
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $70M
Investors
- 5
About BioIntellisense
BioIntellisense, Inc.Founded in 2018 in Golden, US, BioIntellisense, Inc. focuses on remote patient monitoring solutions. The company was established by David Wang and James Mault.BioIntelliSense offers a comprehensive suite of remote patient monitoring (RPM) solutions, anchored by its flagship products, the BioButton® multi-patient wearable device and the BioDashboard™ system. The BioButton® is a rechargeable and reusable medical-grade device designed for continuous vital sign monitoring, enabling high-frequency data collection that supports personalized patient care and proactive clinical interventions. Its applications extend to both hospital settings and home environments, providing care for a variety of patient populations, including those with chronic conditions and those undergoing post-operative recovery.The revenue model of BioIntelliSense primarily revolves around subscription-based services and partnerships with healthcare providers and organizations. Clients typically engage in contractual agreements for the use of the BioButton® wearables and the accompanying BioDashboard™ software, which enables comprehensive health data management and reporting. The structure of these transactions fosters ongoing relationships with healthcare systems, where revenue is generated through both initial device sales and recurring subscription fees for data analytics services. The company’s flagship products, including the BioButton® and BioDashboard™, are positioned to support scalable RPM programs, thereby maximizing revenue potential through increased adoption across healthcare settings.00 mn in July 2021, BioIntellisense, Inc. plans to utilize the capital for continued growth and global expansion of its medical-grade wearable devices and advanced data services for scalable remote care. The company is focused on launching new products and enhancing current offerings to meet the demands of new markets. Specific geographic regions targeted for expansion include international markets, although exact locations have not been specified. These initiatives are aimed at further establishing BioIntelliSense's footprint in remote patient monitoring solutions.
Who invested in BioIntellisense
5 investors across 2 rounds
See all investors in BioIntellisense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioIntellisense
Who invested in BioIntellisense?
BioIntellisense has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioIntellisense raised?
BioIntellisense has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BioIntellisense last raise money?
BioIntellisense's most recent round on record is a Series B, in Jul 2021.
What does BioIntellisense do?
BioIntellisense is a medical devices & equipment company.
Where is BioIntellisense headquartered?
BioIntellisense is headquartered in Golden, US.
Which VCs invest in companies like BioIntellisense?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at BioIntellisense's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like BioIntellisense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.